Tilmacoxib or JTE-522 is a COX-2 and Prostaglandin H synthase-2 inhibitor and is an effective chemopreventive agent against rat experimental liver fibrosis. References: Lee M, Yoo J, Kim JG, Kyung HS, Bin SI, Kang SB, Choi CH, Moon YW, Kim YM, Han SB, In Y, Choi CH, Kim J, Lee BK, Cho S. A Randomized, Multicenter, Phase III Trial to Evaluate the Efficacy and Safety of Polmacoxib Compared with Celecoxib and Placebo for Patients with Osteoarthritis. Clin Orthop Surg. 2017 Dec;9(4):439-457. doi: 10.4055/cios.2017.9.4.439. Epub 2017 Nov 10. PubMed PMID: 29201297; PubMed Central PMCID: PMC5705303.

纯度：≥98%

CAS：180200-68-4